CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 709 enrolled
Drug / intervention
RED-D Care Managementother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01840826
NCT01840826N/ACompleted

Reducing Hospital Readmission Among Medical Patients With Depressive Symptoms

Boston Medical Center·interventional·Posted Apr 26, 2013·Updated Mar 7, 2018

In Brief

A clinical study evaluating RED-D Care Management for Depression. Completed, enrolled 709 participants across 1 site.

Detailed Summary

Project Re-Engineered Discharge (Project RED) has previously demonstrated that patients who received the RED were 30% less likely than patients receiving usual care to access inpatient or emergency services within 30 days of discharge. In this project, the investigators add a new dimension to RED by integrating screening, referral and treatment for depression into the original RED intervention and determining if this enhanced intervention increases the effectiveness of RED in preventing readmissions and controlling costs in the 180 days after discharge for patients with signs of depression.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2013
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 13.2 years ago

Interventions

RED-D Care Managementother

The Case Management intervention will continue for 12 weeks post-discharge (from the index admission).